128 related articles for article (PubMed ID: 11549429)
1. Economic decision analysis model of screening for lung cancer.
Marshall D; Simpson KN; Earle CC; Chu CW
Eur J Cancer; 2001 Sep; 37(14):1759-67. PubMed ID: 11549429
[TBL] [Abstract][Full Text] [Related]
2. Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort.
Marshall D; Simpson KN; Earle CC; Chu C
Lung Cancer; 2001 Jun; 32(3):227-36. PubMed ID: 11390004
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
Das P; Ng AK; Earle CC; Mauch PM; Kuntz KM
Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening.
Wisnivesky JP; Mushlin AI; Sicherman N; Henschke C
Chest; 2003 Aug; 124(2):614-21. PubMed ID: 12907551
[TBL] [Abstract][Full Text] [Related]
6. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Lung Cancer Screening in Canada.
Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
Black WC
J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
[TBL] [Abstract][Full Text] [Related]
9. Current estimate of costs of lung cancer screening in the United States.
Mauchley DC; Mitchell JD
Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of CT screening in the National Lung Screening Trial.
Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C;
N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of computed tomography screening for lung cancer in the United States.
McMahon PM; Kong CY; Bouzan C; Weinstein MC; Cipriano LE; Tramontano AC; Johnson BE; Weeks JC; Gazelle GS
J Thorac Oncol; 2011 Nov; 6(11):1841-8. PubMed ID: 21892105
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
Kent MS; Korn P; Port JL; Lee PC; Altorki NK; Korst RJ
Ann Thorac Surg; 2005 Oct; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
[TBL] [Abstract][Full Text] [Related]
14. Screening for lung cancer with CT: a preliminary cost-effectiveness analysis.
Chirikos TN; Hazelton T; Tockman M; Clark R
Chest; 2002 May; 121(5):1507-14. PubMed ID: 12006436
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of lung cancer screening in Japan.
Okamoto N
Cancer; 2000 Dec; 89(11 Suppl):2489-93. PubMed ID: 11147633
[TBL] [Abstract][Full Text] [Related]
16. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
17. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis.
Puri V; Crabtree TD; Kymes S; Gregory M; Bell J; Bradley JD; Robinson C; Patterson GA; Kreisel D; Krupnick AS; Meyers BF
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):428-36. PubMed ID: 22169443
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.
Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
Scott WJ; Shepherd J; Gambhir SS
Ann Thorac Surg; 1998 Dec; 66(6):1876-83; discussion 1883-5. PubMed ID: 9930463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]